New liver tests aim to better predict outcomes in End-Stage disease
NCT ID NCT01907074
First seen Feb 14, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tested whether a new type of liver function test using a substance called cholate can better measure liver health in people with end-stage liver disease. The goal was to improve how doctors predict outcomes and guide treatment. The study included 103 adults with severe liver scarring or those donating part of their liver.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.